New Initiation - 29 May 2024 i3 Energy* (I3E LN / ITE CN) - A solid platform for E&P growth in Canada
SP Angel’s Post
More Relevant Posts
-
SP Angel was delighted to act as Sole Broker on the recent £1.5m placing completed by its client Mosman Oil and Gas Ltd. The funds raised will allow the Company to pursue and progress identified helium projects, with a view to expanding the Company's helium portfolio.
To view or add a comment, sign in
-
SP Angel is pleased to share that its client Ananda Developments Plc has announced a subscription and placing to raise £2.15m. SP Angel acts as the company's Corporate Adviser and Broker.
To view or add a comment, sign in
-
We are delighted to announce our appointment as Nominated Adviser to Nostra Terra Oil & Gas Company Plc which follows our appointment as Broker in July 2024.
To view or add a comment, sign in
-
SP Angel is delighted to announce its appointment as Broker to POWERHOUSE ENERGY GROUP PLC
To view or add a comment, sign in
-
We are pleased to announce our appointment as Nominated Adviser to Angus Energy Plc which follows our appointment as Broker in April 2024.
To view or add a comment, sign in
-
SP Angel is pleased to announce its appointment as Broker to Nostra Terra Oil & Gas Company Plc.
To view or add a comment, sign in
-
SP Angel is delighted to announce its appointment as Broker to Roquefort Therapeutics plc
To view or add a comment, sign in
-
SP Angel was delighted to sponsor the award for Most Significant Contribution to the Mediscience Sector which was won by Ruth McKernan at last night's European Mediscience Awards 2024. A wonderful evening was had by all. Congratulations to all the well deserving winners!
Huge congratulations to all our incredible winners at last night's European Mediscience Awards 2024, sponsored by HSBC Innovation Banking. We hope you had a wonderful evening celebrating and we look forward to seeing you all again next year! #EMA24 MoonLake Immunotherapeutics (NASDAQ: MLTX) Valneva Tubulis GmbH Brad Loncar BiotechTV Autolus Therapeutics Ruth McKernan Karim Bitar Convatec Zealand Pharma
To view or add a comment, sign in
-
SP Angel is delighted to announce it acted as nominated adviser and broker to CRISM Therapeutics on its admission to trading on AIM on 31 May 2024, following the acquisition of Extruded Pharmaceuticals Limited by Amur Minerals Corporation.
To view or add a comment, sign in
787 followers